Item 2. Management’s Discussion and Analysis
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis (“MD&A”) is intended to provide an understanding of our financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. This discussion should be read in conjunction with the Condensed Consolidated Unaudited Financial Statements contained in this Quarterly Report on Form 10-Q and the Consolidated Financial Statements and related notes and MD&A appearing in our Annual Report on Form 10-K as of and for the year ended December 31, 2021. The results of operations for an interim period may not give a true indication of results for future interim periods or for the year.
Cautionary Statement Regarding Forward Looking Statements
This Quarterly Report on Form 10-Q, including the financial statements and related notes, contains forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations and financial conditions. All forward-looking statements are based on management’s existing beliefs about present and future events outside of management’s control and on assumptions that may prove to be incorrect. If any underlying assumptions prove incorrect, our actual results may vary materially from those anticipated, estimated, projected or intended. We undertake no obligation to publicly update or revise any forward-looking statements to reflect actual results, changes in expectations or events or circumstances after the date of this Quarterly Report on Form 10-Q.
20
Table of Contents
When this report uses the words “we,” “us,” or “our,” and the “Company,” they refer to General Cannabis Corp (formerly, “Advanced Cannabis Solutions, Inc.”).
Our Products, Services, and Customers
Through our two reporting segments, Retail and Cultivation, we provide products to the regulated cannabis industry and its customers, which include the following:
Through our acquisition of TDM, LLC (“TREES Englewood”) in September 2021, our acquisition of Trees Portland, LLC, Trees Waterfront, LLC in December 2021, and our acquisition of Trees MLK, LLC in January 2022, we operate a retail dispensary store in Englewood, Colorado and three retail stores in Portland, Oregon. The Trees MLK location is currently not in operation. This location should be operational in the second quarter of 2022.
Cultivation (“Cultivation Segment”)
Through our acquisition of SevenFive Farm in May 2020, we operate a 17,000 square foot licensed light deprivation greenhouse cultivation facility.
During the three months ended March 31, 2022 and 2021, 45% and 18% of SevenFive’s revenue was with one customer, respectively.
Discontinued Operations - Operations Consulting and Products
Through Next Big Crop, we delivered comprehensive consulting services to the cannabis industry that included obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations.
NBC oversaw our wholesale equipment and supply business, operating under the name “GC Supply,” which provided turnkey sourcing and stocking services to cultivation, retail, and infused products manufacturing facilities. Our products included building materials, equipment, consumables, and compliance packaging. NBC also provided operational support for our internal cultivation. On July 16, 2021, we entered into an Asset Purchase Agreement with an individual to sell substantially all the assets of NBC for a total of $150,000 and 10% of profits generated by the buyer in the states of Michigan, Mississippi, and Massachusetts for a period of twelve months from the closing. On August 2, 2021, the sale of NBC was completed.
Results of Operations
The following tables set forth, for the periods indicated, statements of operations data. The tables and the discussion below should be read in conjunction with the accompanying condensed consolidated financial statements and the notes thereto in this report.
Three months ended March 31,
Percent
2022
2021
Change
Change
Revenues
$
3,573,308
$
663,805
$
2,909,503
438
%
Costs and expenses
(3,990,351)
(1,637,824)
(2,352,527)
144
%
Other expense
(449,296)
(1,371,597)
922,301
(67)
%
Net loss from continuing operations before income taxes
(866,339)
(2,345,616)
1,479,277
(63)
%
Loss from discontinued operations
5,283
(13,452)
18,735
(139)
%
Loss from operations before income taxes
$
(861,056)
$
(2,359,068)
$
1,498,012
(64)
%
21
Table of Contents
Revenues
The addition of our Retail segment contributed to the significant increase in revenues for the three months ended March 31, 2022. See Segment discussions below for further details.
Costs and expenses
Three months ended March 31,
Percent
2022
2021
Change
Change
Cost of sales
$
2,074,888
$
555,205
$
1,519,683
274
%
Selling, general and administrative
1,326,116
598,691
727,425
122
%
Stock-based compensation
76,117
103,932
(27,815)
(27)
%
Professional fees
281,384
262,315
19,069
7
%
Depreciation and amortization
231,846
117,681
114,165
97
%
$
3,990,351
$
1,637,824
$
2,352,527
144
%
Cost of sales increased year over year due to the addition of the Retail Segment in the third and fourth quarters of 2021. See Segment discussions below for further details.
Selling, general and administrative expense increased for the three months ended March 31, 2022, as compared to March 31, 2021, due to the acquisition of three dispensaries in the third and fourth quarter of 2021. This resulted in an increase in employees and an increase in rent expense.
Professional fees consist primarily of accounting and legal expenses and increased slightly for the three months ended March 31, 2022, as compared to the three months ended March 31, 2021, due to the growth of our retail segment.
Stock-based compensation included the following:
Three months ended March 31,
Percent
2022
2021
Change
Change
Employee awards
$
76,117
$
103,932
$
(27,815)
(27)
%
$
76,117
$
103,932
$
(27,815)
(27)
%
Employee awards are issued under our 2020 Omnibus Incentive Plan, which was approved by shareholders on November 23, 2020, and our 2014 Equity Incentive Plan, which was approved by shareholders on June 26, 2015. Expense varies primarily due to the number of stock options granted and the share price on the date of grant. The decrease in expense for the three months ended March 31, 2022, as compared to March 31, 2021, is due to the decrease in the number of options we grant on a quarterly basis and an increase in forfeitures in 2021 due to the departure of our Chief Executive Officer in May 2021, and the departure of our Chief Financial Officer in September 2021.
Other Expense
Three months ended March 31,
Percent
2022
2021
Change
Change
Amortization of debt discount
$
214,281
$
68,330
$
145,951
214
%
Interest expense
174,351
103,056
71,295
69
%
Loss (gain) on derivative liability
60,664
1,198,744
(1,138,080)
(95)
%
Other expenses, net
—
1,467
(1,467)
(100)
%
$
449,296
$
1,371,597
$
(922,301)
(67)
%
Amortization of debt discount increased during the three months ended March 31, 2022, as compared to March 31, 2021, due to the senior convertible promissory notes with warrants (“10% Notes”) issued in December 2020, February 2021, and April 2021. Interest expense increased during the three months ended March 31, 2022, as compared to March 31,
22
Table of Contents
2021, due to the addition of the 10% Notes with an interest rate of 10%. The gain on warrant derivative liability reflects the change in the fair value of the 2019 Warrants.
Retail
Three months ended March 31,
Percent
2022
2021
Change
Change
Revenues
$
3,297,544
$
—
$
3,297,544
100
%
Costs and expenses
(2,593,269)
—
(2,593,269)
100
%
$
704,275
$
—
$
704,275
100
%
With the addition of the TREES Englewood dispensary on September 2, 2021, Trees Portland and Trees Waterfront on December 30, 2021, and Trees MLK on January 5, 2022, we have established our retail footprint in the Colorado and Oregon markets and have become a vertically integrated company. The Retail Segment will provide consistent positive cash flows which will significantly contribute to our working capital position.
Cultivation
Three months ended March 31,
Percent
2022
2021
Change
Change
Revenues
$
518,280
$
649,333
$
(131,053)
(20)
%
Costs and expenses
(707,549)
(786,932)
79,383
(10)
%
$
(189,269)
$
(137,599)
$
(51,670)
38
%
The decrease in revenues for the three months ended March 31, 2022, over prior year is due to the decrease in overall market price of flower. The decrease in gross margin is due to overall increase in expenses due to inflation.
Liquidity
Sources of liquidity
Our sources of liquidity include cash generated from operations, the cash exercise of common stock options and warrants, debt, and the issuance of common stock or other equity-based instruments. We anticipate our significant uses of resources will include funding operations and developing infrastructure.
In September 2021, we received $1,180,000 in cash in a private placement with certain accredited investors pursuant to the Series A Convertible Preferred Stock to be used for the acquisition of dispensaries and for operating capital. (See Note 10 of the accompanying unaudited condensed consolidated financial statements).
In April 2021, we received $2,300,000 in cash in a private placement with certain accredited investors pursuant to the 10% Notes to be used for the acquisition of dispensaries (See Note 7 of the accompanying unaudited condensed consolidated financial statements).
In February 2021, we received $1,660,000 in cash in a private placement with certain accredited investors pursuant to the 10% Notes.
23
Table of Contents
Sources and uses of cash
We had cash of $1,651,063 and $2,054,050 as of March 31, 2022, and December 31, 2021, respectively. Our cash flows from operating, investing and financing activities were as follows:
Three months ended March 31,
2022
2021
Net cash provided by (used in) operating activities
$
45,223
$
(1,449,925)
Net cash used in investing activities
$
(190,153)
$
(55,353)
Net cash provided by (used in) financing activities
$
(258,057)
$
1,595,002
Net cash provided by (used in) operating activities decreased in 2022 due to the acquisition of TREES Englewood, Trees Portland and Trees Waterfront which provides positive operating cash flows and adjustments relating to non-cash activities.
Net cash used in investing activities for the three months ended March 31, 2022, increased from March 31, 2021, due to the purchase of, Trees MLK, Inc and the purchase of property and equipment, offset by the receipt of notes receivable.
Net cash provided by (used in) financing activities for the three months ended March 31, 2022, related to the payment on notes payable of $258,057.
Capital Resources
We had no material commitments for capital expenditures as of March 31, 2022. Part of our growth strategy, however, is to acquire operating businesses. We expect to fund such activity through cash on hand, the issuance of debt, common stock, warrants for our common stock or a combination thereof.
Non-GAAP Financial Measures
Adjusted EBITDA is a non-GAAP financial measure. We define Adjusted EBITDA as net income (loss) attributable to common stockholders calculated in accordance with GAAP, adjusted for the impact of stock-based compensation expense, acquisition or disposal-related transaction costs , non-recurring professional fees in relation to litigation and other non-recurring expenses, depreciation and amortization, amortization of debt discounts and equity issuance costs, loss on extinguishment of debt, interest expense, income taxes and certain other non-cash items. Below we have provided a reconciliation of Adjusted EBITDA per share to the most directly comparable GAAP measure, which is net income (loss) per share.
We believe that the disclosure of Adjusted EBITDA provides investors with a better comparison of our period-to-period operating results. We exclude the effects of certain items when we evaluate key measures of our performance internally and in assessing the impact of known trends and uncertainties on our business. We also believe that excluding the effects of these items provides a more comparable view of the underlying dynamics of our operations. We believe such information provides additional meaningful methods of evaluating certain aspects of our operating performance from period to period on a basis that may not be otherwise apparent on a GAAP basis. This supplemental financial information should be considered in addition to, not in lieu of, our condensed consolidated financial statements.
24
Table of Contents
The following table reconciles Adjusted EBITDA to the most directly comparable GAAP measure, which is net loss.
Three months ended March 31,
2022
2021
Loss from operations before income taxes
$
(866,339)
$
(2,345,616)
Adjustment for loss from discontinued operations
(5,283)
13,452
Net loss from continuing operations before income taxes
(871,622)
(2,332,164)
Adjustments:
Stock-based compensation
76,117
103,932
Depreciation and amortization
231,846
117,681
Amortization of debt discount and equity issuance costs
214,281
68,330
Interest expense
174,351
103,056
Gain on sale of assets
—
1,467
(Gain) loss on derivative liability
60,664
1,198,744
Severance
4,731
—
Acquisition related expenses
7,500
141,580
Total adjustments
769,490
1,734,790
Adjusted EBITDA
$
(102,132)
$
(597,374)
Off-balance Sheet Arrangements
We currently have no off-balance sheet arrangements.
Critical Accounting Policies
Our unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect reported amounts of assets, liabilities, revenues, and expenses. We continually evaluate the accounting policies and estimates used to prepare the condensed financial statements. The estimates are based on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management. Certain accounting policies that require significant management estimates and are deemed critical to our results of operations or financial position are discussed in our Annual Report on Form 10-K for the year ended December 31, 2021, and Note 1 to the Unaudited Condensed Consolidated Financial Statements in this Form 10-Q.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.